Rock Springs Capital Management LP 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:49 pm Purchase | 2024-09-30 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 47,670,850 6.200% | 7,751,595 (+19.42%) | Filing |
| 2024-02-14 2:11 pm Unchanged | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 39,919,255 5.690% | 0 (Unchanged) | Filing |
| 2024-02-14 2:10 pm Purchase | 2023-07-03 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 39,919,255 6.380% | 8,694,770 (+27.85%) | Filing |
| 2023-02-14 2:55 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 31,224,485 5.340% | 25,638,864 (+459.02%) | Filing |
| 2022-02-15 12:44 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 5,585,621 5.130% | 5,585,621 (New Position) | Filing |